|
FATE Fate Therapeutics Inc 1434316 |
| Balance Sheet |
|
Current Assets
|
310,294,000 |
|
Assets
|
494,970,000 |
|
Current Liabilities
|
37,422,000 |
|
Liabilities
|
132,644,000 |
|
Equity
|
362,326,000 |
|
Shares Out
|
113,878,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-95,075,000 |
|
Investing Cash Flow
|
-10,598,000 |
| Market Analysis |
Market Cap
|
357,006,901 |
|
Price
|
1.27 |
|
BVPS
|
3.18 |
|
PB
|
0.40 |
|
EPS
|
-1.71 |
|
PS
|
29.03 |
|
FCF
|
-105,673,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FATE documents filed with the SEC.
FATE Filings
Clear
